At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
SCH: INT: Harnessing the Power of Technology: MOMBA for Postpartum Smoking
In Brief
A Phase 1 clinical trial evaluating MoMba Live Long app & Sensordrone™ carbon-monoxide sensor, Office contingency management, and 2 other interventions for Smoking Cessation. Completed, enrolled 26 participants across 1 site.
Detailed Summary
Through a smartphone platform, financial incentives for smoking abstinence in postpartum women can be delivered remotely, thus minimizing the need for participants to come to the office to receive traditional contingency management.
Study Details
Timeline
Interventions
MoMba Live Long application \& Sensordrone™ carbon-monoxide sensor to deliver contingency management remotely
A control group which will receive financial incentives at an in-person office/clinic visit based on expired CO levels obtained through the piCO sensor.
A custom breath CO meter built by Sensorcon Inc. (Sensordrone, part No. SDRONEG1) that uses an electrochemical CO gas sensor to measure environmental CO. The Sensordrone is accurate to within 10% with a resolution of 1 parts per million (ppm). The Sensordrone pairs via Bluetooth with the MoMba Live Long application.
The MoMba Live Long app provides an interface for the Sensordrone which allows participants to complete a breath test and see results of smoking status. The app verifies the user is correctly taking the tests by recording pictures using the front facing camera as well as recording audio to verify that the participants where exhaling while taking the test. The app also provided a platform for social interaction based on a previous system where app users can interact with each other and provide support during the quitting process.